- Home
- HAS vs RGC Comparison
HAS vs RGC Comparison
Compare HAS & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAS | RGC |
|---|---|---|
| Founded | 1923 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 11.5B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HAS | RGC |
|---|---|---|
| Price | $85.27 | $6.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $109.73 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 165.3K |
| Earning Date | 05-20-2026 | 10-31-2025 |
| Dividend Yield | ★ 2.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $5,365,900,000.00 | N/A |
| Revenue This Year | $5.38 | N/A |
| Revenue Next Year | $6.48 | N/A |
| P/E Ratio | $61.01 | ★ N/A |
| Revenue Growth | ★ 13.06 | N/A |
| 52 Week Low | $69.50 | $7.17 |
| 52 Week High | $106.98 | $69.00 |
Technical Indicators
Market Signals| Indicator | HAS | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 14.88 |
| Support Level | $83.50 | N/A |
| Resistance Level | $86.67 | $16.97 |
| Average True Range (ATR) | 1.86 | 2.33 |
| MACD | 0.43 | -1.08 |
| Stochastic Oscillator | 65.41 | 2.97 |
Price Performance
Historical ComparisonAbout HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to 19 million digital tabletop players.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.